Active ingredient
Methotrexate NDC Codes
Methotrexate is an active ingredient in 20 finished products listed with the FDA, under 4 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Methotrexate, Otrexup, Jylamvo, Xatmep
- Labelers
- Antares Pharma, Inc., Hikma Pharmaceuticals USA Inc., AvPAK, SHORLA ONCOLOGY INC., Azurity Pharmaceuticals, Inc., Zydus Lifesciences Limited, Major Pharmaceuticals, Zydus Pharmaceuticals USA Inc., Accord Healthcare, Inc.
- Strengths
- Methotrexate 25 mg/mL; Methotrexate 2.5 mg/1; Methotrexate 1 g/1; Methotrexate 2 mg/mL; Methotrexate 2.5 mg/mL; Methotrexate 10 mg/.4mL; Methotrexate 12.5 mg/.4mL; Methotrexate 15 mg/.4mL; Methotrexate 17.5 mg/.4mL; Methotrexate 20 mg/.4mL; Methotrexate 22.5 mg/.4mL; Methotrexate 25 mg/.4mL
- Dosage forms
- Injection, Solution, Solution, Tablet, Injection, Powder, Lyophilized, For solution, Injection
- Routes
- Intra-arterial, Intramuscular, Intrathecal, Intravenous, Subcutaneous, Oral
- Drug classes (FDA established)
- Folate Analog Metabolic Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 47
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Methotrexate | Methotrexate 2.5 mg/1 | TabletOral | AvPAK | 50268-554 | 50268-0554-15 | — |
| Jylamvomethotrexate | Methotrexate 2 mg/mL | SolutionOral | SHORLA ONCOLOGY INC. | 81927-204 | 81927-0204-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9516 | 00143-9516-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9517 | 00143-9517-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9518 | 00143-9518-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9519 | 00143-9519-10 | — |
| Xatmepmethotrexate | Methotrexate 2.5 mg/mL | SolutionOral | Azurity Pharmaceuticals, Inc. | 52652-2001 | 52652-2001-0152652-2001-06 | — |
| Methotrexate | Methotrexate 2.5 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1058 | 70771-1058-0070771-1058-0170771-1058-03+3 more | — |
| Methotrexate | Methotrexate 2.5 mg/1 | TabletOral | Major Pharmaceuticals | 0904-7141 | 00904-7141-10 | — |
| Methotrexate | Methotrexate 2.5 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 68382-775 | 68382-0775-0168382-0775-0568382-0775-10+3 more | — |
| Methotrexate | Methotrexate 25 mg/mL | InjectionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Accord Healthcare, Inc. | 16729-277 | 16729-0277-0316729-0277-3016729-0277-35 | — |
| Otrexupmethotrexate | Methotrexate 10 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-010 | 54436-0010-0154436-0010-0354436-0010-04 | — |
| Otrexupmethotrexate | Methotrexate 12.5 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-012 | 54436-0012-0154436-0012-0354436-0012-04 | — |
| Otrexupmethotrexate | Methotrexate 15 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-015 | 54436-0015-0154436-0015-0354436-0015-04 | — |
| Otrexupmethotrexate | Methotrexate 17.5 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-017 | 54436-0017-0154436-0017-0354436-0017-04 | — |
| Otrexupmethotrexate | Methotrexate 20 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-020 | 54436-0020-0154436-0020-0354436-0020-04 | — |
| Otrexupmethotrexate | Methotrexate 22.5 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-022 | 54436-0022-0154436-0022-0354436-0022-04 | — |
| Otrexupmethotrexate | Methotrexate 25 mg/.4mL | Injection, SolutionSubcutaneous | Antares Pharma, Inc. | 54436-025 | 54436-0025-0154436-0025-0354436-0025-04 | — |
| Methotrexate | Methotrexate 1 g/1 | Injection, Powder, Lyophilized, For solutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9830 | 00143-9830-01 | — |
| Methotrexate | Methotrexate 1 g/1 | Injection, Powder, Lyophilized, For solutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | Hikma Pharmaceuticals USA Inc. | 0143-9367 | 00143-9367-01 | — |
Methotrexate: common questions
- Which drugs contain Methotrexate?
- Methotrexate, Otrexup, Jylamvo, Xatmep.
- Is there a J-code for Methotrexate?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.